Camsing Healthcare Limited: Convertible Bond Conversion Update
Camsing Healthcare Limited Announces Significant Convertible Bond Conversions
Key Highlights
- The Board of Directors of Camsing Healthcare Limited has announced the receipt of conversion notices from major investors regarding their convertible bonds.
- Three investors have opted to convert a total principal amount of S\$2.5 million in bonds into ordinary shares at a conversion price of S\$0.05 per share.
- The conversion will result in the issuance of 50,000,000 new shares, potentially impacting the company’s share capital and trading dynamics.
- All conversions are aligned with prior shareholder approvals and the company’s agreement with SGX-ST for listing and quotation of these shares.
Detailed Breakdown of Bond Conversions
The Board received official conversion notices on 7 April 2026 from the following investors:
| Investor |
Principal Amount |
Conversion Price |
New Shares Issued |
| Duanmu Xiaoyi |
S\$700,000 |
S\$0.05 |
14,000,000 |
| Chen Hao |
S\$900,000 |
S\$0.05 |
18,000,000 |
| Liu Jing |
S\$900,000 |
S\$0.05 |
18,000,000 |
This conversion follows the terms of the Convertible Bond Subscription Agreement dated 14 June 2023 and subsequent shareholder approvals at extraordinary general meetings.
Potential Share Price Impact and Shareholder Information
- Significant Dilution: The conversion of bonds into 50,000,000 new shares represents a substantial increase in the company’s share base. This dilution may impact the earnings per share and overall share value.
- Conversion Price: The conversion price remains fixed at S\$0.05 per share, with no adjustments, as confirmed in the company’s circular to shareholders dated 9 May 2024. This is a potentially price-sensitive level that could influence trading activity, especially if the market price differs significantly from the conversion price.
- Regulatory Approval: The Singapore Exchange (SGX-ST) granted in-principle approval for the listing and quotation of up to 50,000,000 conversion shares, ensuring compliance and transparency for investors.
- Further Updates: The company will make additional announcements regarding the allotment and issuance of conversion shares, which may further affect market sentiment and share price.
Key Dates and Progress
- The Convertible Bond Subscription Agreement was executed on 14 June 2023.
- Shareholders approved related resolutions at extraordinary general meetings held on 9 May, 24 May, and 19 June 2024.
- SGX-ST approval for listing of conversion shares was obtained on 2 May 2024.
- Conversion notices were received on 7 April 2026.
- Completion of the new investment was announced on 3 July 2024.
Conclusion
This update represents a significant corporate action that could affect Camsing Healthcare Limited’s share price. The issuance of 50 million new shares at S\$0.05 each signals major investor confidence but also introduces dilution risks. Shareholders and market participants should monitor subsequent company announcements for further developments regarding the allotment and trading of these new shares.
Disclaimer
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors are advised to review official company filings and consult with professional financial advisors before making any investment decisions.
View Camsing Hc Historical chart here
